Funded Awards – December 2017

Funded Awards
PI Agency Title
Mary Dinauer NIH/R01/University of Southern California Leukocyte NADPH Oxidase Variants in Lupus
Todd Druley CDI Applying Error-Corrected Sequencing to Detect Minimal …
Sarah Garwood St. Louis County Children’s Service Fund Jennings School-Based Health Clinic
Monica Hulbert NIH/R01/Medical University of South Carolina DISPLACE: Dissemination and Implementation of Stroke P…
Mark Lowe NIH/U01/University of Iowa Consoritum for the Study of Chonic Pancreatitis, Diabe…
Jose Pineda SLCH Foundation/Research Grant Sigma Sigma Sigma Foundation 2017 Grant
Katie Plax St. Louis County Children’s Service Fund The Spot
Laura Schuettpelz American Cancer Society/Clinical Research Scholar Grant Role of TLR2 Signaling in the Transformation of MDS
Shalini Shenoy NIH/National Marrow Donor Program NMDP BMT CTN#1507 (Sickle Cell) Per Patient Reimbursem…
Gregory Storch HRSA/HRI, Inc. QI Contract Schlueter
Funded Awards
Funded Grants September 2021

PI Agency Title Megan Cooper NIH/ UG3/UH3/Baylor College of Medicine Safety and Efficacy of Itacitinib in treatment of JAK/STAT gain of function disorders Amjad Horani CDI Mechanisms of Primary Ciliary Dyskinesia Cynthia Ortinau Brain & Behavior Research Foundation Association of Parental Psychological Distress with Brain and Neurodevelopment in Congenital Heart …

Funded Awards
Funded Grants August 2021

PI Agency Title Fahd Ahmad NIH/CCHMC EMS for Children: Pediatric Emergency Care Applied Research Network (PECARN)  Jonathan Cooper NIH/R56 Characterizing and testing the efficacy of AAV-mediated gene therapy in a novel CRISPR/Cas9 generated sheepmodel of Cln1 disease. Jorge Di Paola NIH/R01/Ohio State University A Reversible Aptamer Based Therapeutic to Treat …

Funded Awards
Funded Grants July 2021

PI Agency Title Mohamed Abdelbaki EIF/The Hospital for Sick Children 3CI Study: Childhood Cancer Combination Immunotherapy. Phase 1b and Expansion Study of Nivolumab Combination Immunotherapy in Children, Adolescent and Young Adult (CAYA) Patients with Relapsed/Refractory Hypermutant Cancers Amy Armstrong Aflac Foundation/Children’s Healthcare of Atlanta A Maintenance Protocol of Sirolimus in …